We’ve been waiting for years. The FDA today approved the first-ever “anti-cancer vaccine.” Provenge, made by blossoming biotech company Dendreon in Seattle, is a personalized therapy designed to give a second chance for a patient’s own immune system to beat back advanced prostate cancer.
It is, by no means, for every prostate cancer patient (more [...]
